Treatment.com AI Secures Financing Through Private Placement
Treatment.com AI Inc. is excited to announce its latest initiative for growth by pursuing a non-brokered private placement aimed at raising up to C$3 million. This decision comes in response to significant interest from both new and existing investors, highlighting the company's promising direction and the increasing recognition of its innovative healthcare solutions.
Details of the Private Placement
The private placement includes a combination of special warrants and units, each priced at C$0.50. Each unit consists of one common share and a common share purchase warrant. Investors will find value in these warrants, as they provide the opportunity to purchase shares at a set price of C$0.75 per share for a period of 12 months following issuance.
Conversion Process for Special Warrants
Investors in special warrants will enjoy the benefit of automatic conversion into units without any additional payment required. This automatic conversion will occur on specified dates, ensuring a seamless transition for investors as they engage with the offerings.
Use of Proceeds from the Offering
The proceeds from this funding initiative are primarily earmarked for working capital purposes. This strategic move is expected to enhance Treatment.com AI's operational capabilities, allowing for further innovation in the healthcare sector.
Expectations and Regulatory Approval
As the company prepares for this offering, it aims to file a prospectus supplement within 60 days following the closing. This filing is critical for qualifying the distribution of shares and warrants associated with this offering. The success of the private placement hinges not only on investor interest but also on the necessary approvals from regulatory bodies, including the Canadian Securities Exchange.
Promotion of Investor Engagement
Treatment.com AI acknowledges the importance of investor relations and may pay finder’s fees up to 8% of gross proceeds. Additionally, broker warrants may be issued to eligible finders, further incentivizing participation in the offering.
About Treatment.com AI Inc.
Treatment.com AI is at the forefront of integrating artificial intelligence in healthcare. By leveraging the insights of hundreds of healthcare professionals, the company has established the Global Library of Medicine (GLM). This robust platform delivers accurate clinical information and support to practitioners, facilitating better patient care.
Enhancing Healthcare Efficiency
The GLM provides healthcare professionals with essential tools and resources to streamline their workflows, thus allowing them to devote more time to patient interactions. This innovative approach not only enhances the quality of care but also supports communities that often face healthcare challenges.
Contact Information
For more detailed inquiries about Treatment.com AI, please contact Dr. Essam Hamza, CEO, via email at ehamza@treatment.com. Alternatively, reach out for media inquiries at media@treatment.com.
For additional information, you can call +1 (612) 788-8900 or toll-free in the USA/Canada at +1 (888) 788-8955.
Frequently Asked Questions
What is the purpose of the private placement by Treatment.com AI?
The private placement aims to raise funds for working capital needs and to enhance Treatment.com AI's operational capabilities.
How much funding is Treatment.com AI looking to raise?
The company is targeting up to C$3 million through this private placement initiative.
What are special warrants and units in this context?
Special warrants are convertible into units, which consist of common shares and purchase warrants, offering investment opportunities to participants.
What will Treatment.com AI do with the proceeds?
The funds will primarily be used for working capital to support the company's ongoing operations and innovations.
Who can participate in the offering?
The offering is available to both new and existing investors interested in supporting Treatment.com AI's mission in the healthcare sector.
